KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 220 filers reported holding KITE PHARMA INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $7,297,000 | +125.5% | 263,584 | +45.3% | 0.27% | +130.3% |
| Q2 2017 | $3,236,000 | +37.4% | 181,349 | +18.3% | 0.12% | +21.4% |
| Q1 2017 | $2,355,000 | +615.8% | 153,263 | +53.3% | 0.10% | +716.7% |
| Q4 2016 | $329,000 | -69.1% | 99,966 | -49.9% | 0.01% | -75.0% |
| Q3 2016 | $1,064,000 | +66.0% | 199,678 | +209.2% | 0.05% | +45.5% |
| Q2 2016 | $641,000 | +0.9% | 64,578 | -32.4% | 0.03% | -21.4% |
| Q1 2016 | $635,000 | -39.4% | 95,478 | -15.0% | 0.04% | -27.6% |
| Q4 2015 | $1,047,000 | – | 112,379 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|